Schizophrenia Clinical Trial
Official title:
Music Therapy for Treatment of Patients Suffering From Schizophrenia With Negative Symptoms - A Double-blinded Study
The Aim of this National study is to examine whether music therapy can reduce negative
symptoms and raise Quality of Life for patients suffering from Schizophrenia. It is an
Randomized Controlled Trial (RCT), double-blinded study with two arms. 120 Participants are
anticipated. The two Arms consist of 25 weekly hours of Music Therapy by educated Music
Therapists and time compensated Music Listening by unknown Care Staff Members.
The Study is a close Cooperation between Aalborg University (The Music Therapy Research
Clinic) and Aalborg University Hospital, Psychiatry.
Schizophrenia includes 1 % of the Population in Denmark (DK) and often ends up to be
chronically. Negative Symptoms are difficult to reduce by Medication and Psychosocial
Treatment Possibilities are searched for. Three Cochrane Reviews (2005, 2011, 2017) have been
conducted concerning Music Therapy and Schizophrenia with Positive Results. This RCT,
double-blinded Study aims at verifying, if these Results can be Recognized in the Danish
Health System. It also aims at being similar to Biomedical Study Designs as much as possible
to strengthen the Evidence of the Study. A Power Calculation showed, that a minimum of 44,5
Participants in each Arm should be available, but as drop out can be anticipated with this
Population, 60 Participants in each Arm were recommended. The screening Procedure is
Comprehensive as it aims at securing, that the negative Symptoms are part of the Illness
Schizophrenia and not side Effects from Medication or simultaneous Depression (See the
Inclusion- and Exclusion criteria).
The Measurement Tools are as follows:
At Baseline, after 15 Sessions and at Termination:
- The Positive and Negative Syndrome Scale (PANSS),
- Brief Negative Symptom Scale (BNSS),
- Quality of Life (WHOQOL-Bref),
- Calgary Depression Scale for Schizophrenia (CDSS),
- Board of Clinical Examinations (Danish Questionnaire) (UKU)
- Global Assessment of Functioning Scale (GAF) 4 Weeks after Termination Follow Up
Interview. In the Arm of Music Therapy Audio Recording of Music Interventions are done
in Session 1,15 and 25.
- Helping Alliance Questionnaire, patient version, (Haq-II) This Haq-II is filled out
after 5 sessions and after 15 Sessions and at Termination together with a Research
Assistant in both Arms.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |